BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Sibley L, Gooch K, Wareham A, Gray S, Chancellor A, Dowall S, Bate S, Marriott A, Dennis M, White AD, Marsh PD, Fletcher H, Sharpe S. Differences in monocyte: lymphocyte ratio and Tuberculosis disease progression in genetically distinct populations of macaques. Sci Rep 2019;9:3340. [PMID: 30833652 DOI: 10.1038/s41598-019-39819-6] [Cited by in Crossref: 6] [Cited by in F6Publishing: 5] [Article Influence: 2.0] [Reference Citation Analysis]
Number Citing Articles
1 Carranza C, Carreto-binaghi LE, Guzmán-beltrán S, Muñoz-torrico M, Torres M, González Y, Juárez E. Sex-Dependent Differential Expression of Lipidic Mediators Associated with Inflammation Resolution in Patients with Pulmonary Tuberculosis. Biomolecules 2022;12:490. [DOI: 10.3390/biom12040490] [Reference Citation Analysis]
2 Sibley L, White AD, Gooch KE, Stevens LM, Tanner R, Jacobs A, Daykin-Pont O, Gleeson F, McIntyre A, Basaraba R, Clark S, Hall G, Pearson G, Rayner E, McShane H, Williams A, Dennis M, Marsh PD, Sharpe S. High-dose Mycobacterium tuberculosis aerosol challenge cannot overcome BCG-induced protection in Chinese origin cynomolgus macaques; implications of natural resistance for vaccine evaluation. Sci Rep 2021;11:12274. [PMID: 34112845 DOI: 10.1038/s41598-021-90913-0] [Reference Citation Analysis]
3 Zanon IDB, Tsai VL, Ribeiro TC, Astur N, Mendonça RGMD, Gotfryd AO, Salles MJC, Caffaro MFS, Klautau GB, Meves R. THE PROFILE OF POTT’S DISEASE IN A SOUTH AMERICAN REFERENCE SERVICE. Coluna/Columna 2021;20:109-13. [DOI: 10.1590/s1808-185120212002234844] [Reference Citation Analysis]
4 Sibley L, Daykin-Pont O, Sarfas C, Pascoe J, White AD, Sharpe S. Differences in host immune populations between rhesus macaques and cynomolgus macaque subspecies in relation to susceptibility to Mycobacterium tuberculosis infection. Sci Rep 2021;11:8810. [PMID: 33893359 DOI: 10.1038/s41598-021-87872-x] [Reference Citation Analysis]
5 Khan A, Zhang K, Singh VK, Mishra A, Kachroo P, Bing T, Won JH, Mani A, Papanna R, Mann LK, Ledezma-Campos E, Aguillon-Duran G, Canaday DH, David SA, Restrepo BI, Viet NN, Phan H, Graviss EA, Musser JM, Kaushal D, Gauduin MC, Jagannath C. Human M1 macrophages express unique innate immune response genes after mycobacterial infection to defend against tuberculosis. Commun Biol 2022;5:480. [PMID: 35590096 DOI: 10.1038/s42003-022-03387-9] [Reference Citation Analysis]
6 Prescott MJ, Clark C, Dowling WE, Shurtleff AC. Opportunities for Refinement of Non-Human Primate Vaccine Studies. Vaccines (Basel) 2021;9:284. [PMID: 33808708 DOI: 10.3390/vaccines9030284] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
7 Yang HJ, Wang D, Wen X, Weiner DM, Via LE. One Size Fits All? Not in In Vivo Modeling of Tuberculosis Chemotherapeutics. Front Cell Infect Microbiol 2021;11:613149. [PMID: 33796474 DOI: 10.3389/fcimb.2021.613149] [Reference Citation Analysis]
8 Saricam M. Efficiency of Lymphocyte-to-Monocyte Ratio in Differential Diagnosis of Parapneumonic Effusion and Thoracic Empyema. Surg Infect (Larchmt) 2020;21:891-4. [PMID: 32310736 DOI: 10.1089/sur.2019.346] [Reference Citation Analysis]